Nobuyuki Takada

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients

Toshio Ohkuma, Taro Minagawa, Nobuyuki Takada et al. · American Journal of Kidney Diseases · 2003 · 45 citations

Medicine, Nephrology, Dialysis +12

RNAi mediated inhibition of viroid infection in transgenic plants expressing viroid-specific small RNAs derived from various functional domains

Charith Raj Adkar‐Purushothama, Atsushi Kasai, Kohei Sugawara et al. · Scientific Reports · 2015 · 37 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

The role of alpha and beta adrenergic receptors in constriction and dilation of the systemic capacitance vessels: A study with measurements of the mean circulatory pressure in dogs.

Senri Hirakawa, Hiroyasu Itoh, Yasunori Kotoo et al. · Japanese Circulation Journal · 1984 · 27 citations · Full text

Medicine, Pharmacology, Physiology +15

307. EFFICACY OF PRIMARY TREATMENT WITH IMMUNOGLOBULIN PLUS CYCLOSPORINE FOR PREVENTION OF CORONARY ARTERY ABNORMALITIES IN KAWASAKI DISEASE PATIENTS PREDICTED TO BE AT INCREASED RISK OF IVIG NON- RESPONSE (KAICA STUDY): A CONTROLLED, PHASE 3, RANDOMISED, OPEN-LABEL, BLINDED-ENDPOINTS TRIAL

Hiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi et al. · Lara D. Veeken · 2019 · 13 citations · Full text

Medicine, Immunology, Pharmacology +11